Senile plaque composition and posttranslational modification of amyloid-β peptide and associated proteins
暂无分享,去创建一个
George Perry | R. Martins | Mark A. Smith | C. Atwood | Mark A Smith | Craig S Atwood | Ralph N Martins | George Perry
[1] R. Kalaria,et al. Expression of leukocyte antigen CD34 by brain capillaries in Alzheimer's disease and neurologically normal subjects , 2004, Acta Neuropathologica.
[2] C. Geula,et al. Anatomy of cholinesterase inhibition in Alzheimer's disease: Effect of physostigmine and tetrahydroaminoacridine on plaques and tangles , 1987, Annals of neurology.
[3] Khadija Iqbal,et al. Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia , 2004, Acta Neuropathologica.
[4] W. Griffin,et al. Microglial inter leukin‐1α expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution , 1995, Neuropathology and applied neurobiology.
[5] Ashley I. Bush,et al. Redox-active iron mediates amyloid-β toxicity , 2001 .
[6] E. Masliah,et al. Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic. , 1995, Biochemistry.
[7] S. Ju,et al. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[8] E M Wijsman,et al. A familial Alzheimer's disease locus on chromosome 1 , 1995, Science.
[9] R N Kalaria,et al. Induction of Heme Oxygenase‐1 mRNA and Protein in Neocortex and Cerebral Vessels in Alzheimer's Disease , 1995, Journal of neurochemistry.
[10] E. Perry,et al. ALUMINOSILICATES AND SENILE PLAQUE FORMATION IN ALZHEIMER'S DISEASE , 1986, The Lancet.
[11] Alfredo G. Tomasselli,et al. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity , 1999, Nature.
[12] D. Nochlin,et al. Identification and Immunolocalization of a New Class of Proteoglycan (Keratan Sulfate) to the Neuritic Plaques of Alzheimer's Disease , 1996, Experimental Neurology.
[13] B. Shapiro,et al. Release of ovoperoxidase from sea urchin eggs hardens the fertilization membrane with tyrosine crosslinks. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[14] B. Hyman,et al. Quantitation of apoE Domains in Alzheimer Disease Brain Suggests a Role for apoE in Aß Aggregation , 2001, Journal of neuropathology and experimental neurology.
[15] R. Kalaria,et al. Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders , 1991, Neuropathology and applied neurobiology.
[16] E. Masliah,et al. Myeloperoxidase Polymorphism Is Associated with Gender Specific Risk for Alzheimer's Disease , 1999, Experimental Neurology.
[17] Xudong Huang,et al. Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc* , 2000, The Journal of Biological Chemistry.
[18] G. Irvine,et al. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins. , 2000, Journal of structural biology.
[19] P. Mantyh,et al. Brain Amyloid — A Physicochemical Perspective , 1996, Brain pathology.
[20] D. Graham,et al. βA4 amyloid protein deposition in brain after head trauma , 1991, The Lancet.
[21] T. Benzinger,et al. Two-Dimensional Structure of β-Amyloid(10−35) Fibrils† , 2000 .
[22] G. Glenner,et al. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. , 1984, Biochemical and biophysical research communications.
[23] G. Perry,et al. Neuronal Oxidative Stress Precedes Amyloid‐β Deposition in Down Syndrome , 2000 .
[24] R. Scott,et al. Processing of the beta-amyloid precursor. Multiple proteases generate and degrade potentially amyloidogenic fragments. , 1993, The Journal of biological chemistry.
[25] M. Lerman,et al. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. , 1987, Science.
[26] A. Peters,et al. The Structure of Neuritic Plaques in the Cerebral Cortex of Aged Rats , 1981, Journal of neuropathology and experimental neurology.
[27] D. Mann,et al. Dominant and differential deposition of distinct β-amyloid peptide species, Aβ N3(pE), in senile plaques , 1995, Neuron.
[28] S. Arlt,et al. Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma , 2001 .
[29] S. Squazzo,et al. Aggregation of Secreted Amyloid -Protein into Sodium Dodecyl Sulfate-stable Oligomers in Cell Culture (*) , 1995, The Journal of Biological Chemistry.
[30] C. Cotman,et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.
[31] P. Fraser,et al. An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar aβ-amyloid in rat brain , 1994, Neuron.
[32] S. Mirra,et al. Neuritic Plaque Amyloid in Alzheimer's Disease Is Highly Racemized , 1988, Journal of neurochemistry.
[33] Min Xu,et al. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[34] C. Geula,et al. Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue , 1991, Brain Research.
[35] D. Allsop,et al. The isolation and amino acid composition of senile plaque core protein , 1983, Brain Research.
[36] B. Hyman,et al. Microglial response to amyloid plaques in APPsw transgenic mice. , 1998, The American journal of pathology.
[37] P. Cras,et al. Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[38] J. Wegiel,et al. Review: David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines * , 1996, Neuropathology and applied neurobiology.
[39] A. Scheibel,et al. Immunodetection of the amyloid P component in Alzheimer's disease , 2004, Acta Neuropathologica.
[40] H. Kresse,et al. Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[41] D. Perl,et al. Evidence of neuronal oxidative damage in Alzheimer's disease. , 1996, The American journal of pathology.
[42] D. Price,et al. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. , 1995, The American journal of pathology.
[43] P. Lansbury,et al. Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic beta-protein fragments. , 1990, Biochemistry.
[44] N. Robakis,et al. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease , 1992 .
[45] B. Corain. Alzheimer's disease : advances in clinical and basic research , 1993 .
[46] H. Chui,et al. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease , 1990, Brain Research.
[47] R. Tanzi,et al. Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. , 1999, Metal ions in biological systems.
[48] J. D. Robertson,et al. Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.
[49] Min Xu,et al. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 , 2000, Nature.
[50] S. Styren,et al. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease , 1988, Neurobiology of Aging.
[51] S M Breathnach,et al. Amyloid and amyloidosis. , 1988, Journal of the American Academy of Dermatology.
[52] U. Schreiter-Gasser,et al. Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices , 1991, FEBS letters.
[53] R. Nixon,et al. Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease , 1994, Brain Research.
[54] K. Beyreuther,et al. Amyloidogenicity of rodent and human βA4 sequences , 1993 .
[55] E. Masliah,et al. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. , 1996, The American journal of pathology.
[56] C. Geula,et al. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease , 1989, Brain Research.
[57] D. Selkoe,et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity , 1999, Nature.
[58] W. Markesbery,et al. N‐terminal Heterogeneity of Parenchymal and Cerebrovascular Aβ Deposits , 1998, Journal of neuropathology and experimental neurology.
[59] G. Perry,et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[60] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[61] B. Hyman,et al. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APPV717F transgenic mice , 2000, Acta Neuropathologica.
[62] Y. Takahashi,et al. Identification of the disulfide bonds in human plasma protein SP-40,40 (apolipoprotein-J). , 1992, Journal of biochemistry.
[63] R. Martins,et al. Anti-apoptotic action of Alzheimer Ab , 1999 .
[64] G. Perry,et al. Amyloid P component and other acute-phase proteins associated with cerebellar Aβ-deposits in Alzheimer's disease , 1993, Brain Research.
[65] C. Masters,et al. Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion* , 1999, The Journal of Biological Chemistry.
[66] M. Yoshimoto,et al. NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[67] P. Briza,et al. Candida albicans cell walls contain the fluorescent cross-linking amino acid dityrosine , 1995, Infection and immunity.
[68] D. Selkoe,et al. Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1 , 2000, Nature Cell Biology.
[69] Eric J. Simon,et al. Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide , 1995, Nature Structural Biology.
[70] Mark A. Smith,et al. 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.
[71] E. Bird,et al. Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin , 1990, Brain Research.
[72] D. Selkoe,et al. Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. , 1992, The Journal of biological chemistry.
[73] W. Griffin,et al. Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression , 1996, Neuropathology and applied neurobiology.
[74] J. Silver,et al. Astrocytes Regulate Microglial Phagocytosis of Senile Plaque Cores of Alzheimer's Disease , 1998, Experimental Neurology.
[75] H. Vinters,et al. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. , 1990, The American journal of pathology.
[76] A. Nunomura,et al. Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.
[77] Akihiko Iwai,et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.
[78] D. Beauchemin,et al. A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques. , 1998, Analytical chemistry.
[79] G. Perry,et al. α1-Trypsin Immunoreactivity in Alzheimer Disease , 1993 .
[80] B T Hyman,et al. Growth Arrest of Individual Senile Plaques in a Model of Alzheimer's Disease Observed by In Vivo Multiphoton Microscopy , 2001, The Journal of Neuroscience.
[81] B. Winblad,et al. Alzheimer's disease : advances in etiology, pathogenesis, and therapeutics , 2001 .
[82] P. S. St George-Hyslop,et al. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.
[83] R. Strohmeyer,et al. Molecular and cellular mediators of Alzheimer's disease inflammation. , 2001, Journal of Alzheimer's disease : JAD.
[84] T. Wight,et al. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses , 1989, Neurobiology of Aging.
[85] M. Smith,et al. Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin? , 1999, Free radical biology & medicine.
[86] F. Shimizu,et al. Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique , 1975, Acta Neuropathologica.
[87] L. Haverkamp,et al. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain , 1995, Neurochemistry International.
[88] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.
[89] J. Treanor,et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.
[90] P. Lansbury,et al. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? , 1995, Chemistry & biology.
[91] Xudong Huang,et al. Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. , 2008, Journal of neurochemistry.
[92] G. Perry,et al. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[93] D. Holtzman,et al. α2‐Macroglobulin Complexes with and Mediates the Endocytosis of β‐Amyloid Peptide via Cell Surface Low‐Density Lipoprotein Receptor‐Related Protein , 1997 .
[94] R. Mrak,et al. Correlation of Astrocytic S100β Expression with Dystrophic Neurites in Amyloid Plaques of Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.
[95] David G. Tew,et al. Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase , 1999, Molecular and Cellular Neuroscience.
[96] H. Vinters,et al. Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy , 1990, Annals of neurology.
[97] D. Munoz,et al. Role of microglia in senile plaque formation , 1995, Neurobiology of Aging.
[98] H. Yamaguchi,et al. Microglial activation in early stages of amyloid β protein deposition , 1997, Acta Neuropathologica.
[99] B. Hyman,et al. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.
[100] R. Martins,et al. A4 amyloid protein deposition and the diagnosis of Alzheimer's disease , 1988, Neurology.
[101] Brian J Cummings,et al. β-Amyloid converts an acute phase injury response to chronic injury responses , 1996, Neurobiology of Aging.
[102] J. Reed,et al. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .
[103] G. Perry,et al. Microglia are associated with the extracellular neurofibrillary tangles of alzheimer disease , 1991, Brain Research.
[104] M. Pericak-Vance,et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[105] P. Mcgeer,et al. Activation of the classical complement pathway in brain tissue of Alzheimer patients , 1989, Neuroscience Letters.
[106] R. Kalaria,et al. Factors Affecting Pro- and Anti-Oxidant Properties of Fragments of the b-Protein Precursor (bPP): Implication for Alzheimer's Disease. , 2000, Journal of Alzheimer's disease : JAD.
[107] R. Tanzi,et al. Copper catalyzed oxidation of Alzheimer Abeta. , 2000, Cellular and molecular biology.
[108] P. S. St George-Hyslop,et al. Phosphorylation, Subcellular Localization, and Membrane Orientation of the Alzheimer's Disease-associated Presenilins* , 1997, The Journal of Biological Chemistry.
[109] J. Silver,et al. Chondroitin Sulfate Proteoglycans Are Associated with the Lesions of Alzheimer's Disease , 1993, Experimental Neurology.
[110] T. Iwatsubo,et al. Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain , 1996, Neuroscience Letters.
[111] M J Ball,et al. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. , 1993, The Journal of biological chemistry.
[112] R. Bucala,et al. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[113] G. Glenner,et al. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .
[114] T. Wight,et al. Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril Stability , 1997 .
[115] G. Perry,et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. , 1994, The American journal of pathology.
[116] L. Goodman. Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. , 1953, The Journal of nervous and mental disease.
[117] C. Franceschi,et al. In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[118] R. Kalaria,et al. Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease , 1990, Brain Research.
[119] Y. Ihara,et al. Appearance of Sodium Dodecyl Sulfate-Stable Amyloid β-Protein (Aβ) Dimer in the Cortex During Aging , 1999 .
[120] E. Masliah,et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[121] R. Barbour,et al. Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.
[122] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[123] M. Tabaton,et al. Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress , 1998, Journal of neurochemistry.
[124] D. Selkoe,et al. Immunochemical identification of the serine protease inhibitor α 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease , 1988, Cell.
[125] P. Greengard,et al. Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[126] B. Sommer,et al. Association of microglia with amyloid plaques in brains of APP23 transgenic mice. , 1999, The American journal of pathology.
[127] D. Nochlin,et al. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. , 1988, The American journal of pathology.
[128] P. Lewitt,et al. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders , 1996, Brain Research.
[129] Y. Ihara,et al. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. , 1987, Science.
[130] S. Younkin,et al. Amyloid β protein (Aβ) removal by neuroglial cells in culture , 1995, Neurobiology of Aging.
[131] M. Emmerling,et al. Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.
[132] Joseph S. Beckman,et al. Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.
[133] P. Cras,et al. Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[134] K. Beyreuther,et al. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. , 1992, The Journal of biological chemistry.
[135] K. Grzeschik,et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.
[136] S. Estus,et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.
[137] M. Ball,et al. Water-soluble A(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains (*) , 1996, The Journal of Biological Chemistry.
[138] V. Chau,et al. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[139] W. Markesbery,et al. Electrochemical Analysis of Protein Nitrotyrosine and Dityrosine in the Alzheimer Brain Indicates Region-Specific Accumulation , 1998, The Journal of Neuroscience.
[140] S. Styren,et al. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain , 1990, Experimental Neurology.
[141] R. Mrak,et al. Interleukin‐1 Expression in Different Plaque Types in Alzheimer's Disease: Significance in Plaque Evalution , 1995, Journal of neuropathology and experimental neurology.
[142] R. Kalaria,et al. Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease , 1992, Neuroscience.
[143] E. Otomo,et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.
[144] M. Smith,et al. Neuronal RNA Oxidation in Alzheimer's Disease and Down's Syndrome , 1999, Annals of the New York Academy of Sciences.
[145] P. Cras,et al. Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. , 1990, The American journal of pathology.
[146] D. Selkoe,et al. Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. , 1998, Biochemistry.